Pioneering preoperative anti-PD-1 immunotherapy enables curative resection in dMMR advanced/recurrent endometrial carcinoma: a case series (2020-2022).
APA
Fu H, Yang B, et al. (2026). Pioneering preoperative anti-PD-1 immunotherapy enables curative resection in dMMR advanced/recurrent endometrial carcinoma: a case series (2020-2022).. Discover oncology. https://doi.org/10.1007/s12672-026-04917-1
MLA
Fu H, et al.. "Pioneering preoperative anti-PD-1 immunotherapy enables curative resection in dMMR advanced/recurrent endometrial carcinoma: a case series (2020-2022).." Discover oncology, 2026.
PMID
41885998
같은 제1저자의 인용 많은 논문 (5)
- [Clinical strategies for perioperative management of esophageal squamous cell carcinoma in the immunotherapy era].
- A smart gene circuit for precise regulation of tumor cell behavior.
- Early gastric cancer with malignant invasion into the duodenum: A case report.
- Superoxide dismutase promotes gastric tumorigenesis mediated by and enhances resistance to 5-fluorouracil in gastric cancer.
- Integrating intratumoral, peritumoral, and clinical features in an ultrasound-based radiomics model: contributions and synergies for predicting microvascular invasion in hepatocellular carcinoma.